Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Stetler-Stevenson Website

William G. Stetler-Stevenson, M.D., Ph.D.

Selected Publications

1)  Han H, Bourboulia D, Jensen-Taubman S, Isaac B, Wei B, Stetler-Stevenson WG.
An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells.
Oncogene. 33: 1198-206, 2014.
[Journal]
2)  Kim SH, Cho YR, Kim HJ, Oh JS, Ahn EK, Ko HJ, Hwang BJ, Lee SJ, Cho Y, Kim YK, Stetler-Stevenson WG, Seo DW.
Antagonism of VEGF-A-induced increase in vascular permeability by an integrin a3ß1-Shp-1-cAMP/PKA pathway.
Blood. 120: 4892-902, 2012.
[Journal]
3)  Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG.
TIMP-2 Mediated Inhibition of Angiogenesis: An MMP-Independnet Mechanism.
Cell. 114: 171-180, 2003.
[Journal]
4)  Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V.
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.
Science. 277: 225-8, 1997.
[Journal]
5)  Stetler-Stevenson WG, Aznavoorian S, Liotta LA.
Tumor cell interactions with the extracellular matrix during invasion and metastasis.
Annu. Rev. Cell Biol. 9: 541-73, 1993.
[Journal]
6)  Mollapour M, Bourboulia D, Beebe K, Woodford MR, Polier S, Hoang A, Chelluri R, Li Y, Guo A, Lee MJ, Fotooh-Abadi E, Khan S, Prince T, Miyajima N, Yoshida S, Tsutsumi S, Xu W, Panaretou B, Stetler-Stevenson WG, Bratslavsky G, Trepel JB, Prodromou C, Neckers L.
Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.
Mol. Cell. 53: 317-29, 2014.
[Journal]
7)  Shuman Moss LA, Jensen-Taubman S, Rubinstein D, Viole G, Stetler-Stevenson WG.
Dietary intake of a plant phospholipid/lipid conjugate reduces lung cancer growth and tumor angiogenesis.
Carcinogenesis. [Epub ahead of print], 2014.
[Journal]
8)  Stetler-Stevenson WG, Gavil NV.
Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic.
Connect. Tissue Res. 55: 13-9, 2014.
[Journal]
9)  Shuman Moss LA, Stetler-Stevenson WG.
Influence of Stromal Components on Lung Cancer Carcinogenesis.
J Carcinog Mutagen. 13, 2013.
[Journal]
10)  Fang C, Avis I, Bianco C, Held N, Morris J, Ylaya K, Hewitt SM, Aplin AC, Nicosia RF, Fung LA, Lewis JD, Stetler-Stevenson WG, Salomon DS, Cuttitta F.
SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells.
Open J Clin Diagn. 3: 37-51, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 7/2/2014.